iShares U.S. Pharmaceuticals ETF IHE
111.08 USD +0.62 (+0.56%)
At closeNov 11, 2026, 4:00 PM EST
113.15 +2.07 +1.86%
After hours · Nov 11, 4:00 PM ET
109.50 Day range 111.13
79.82 52-week range 111.13
- YTD
- +30.94%
- 1 year
- +39.20%
News
fool.com Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT? iShares U.S. Pharmaceuticals ETF has a lower expense ratio than the First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated…
zacks.com ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win Eli Lilly's sleep apnea breakthrough amid the FDA's vision-loss warning puts diversified healthcare ETFs in the spotlight.
zacks.com Pharmaceuticals ETF (IHE) Hits a New 52-Week High For investors seeking momentum, iShares U.S. Pharmaceuticals ETF IHE is probably on the radar. The fund just hit a 52-week high and is up 42.76% from its 52-week low price of $77.52/share.
fool.com Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors The iShares U.S. Pharmaceuticals ETF offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF. The iShares Biotechnology ETF provides exposure to a…
benzinga.com Alphabet Sinks 11.8%, Small Caps Rally on Strong GDP Growth: Stock Market Today Alphabet's capex-heavy quarter drags the Nasdaq 100 lower while GDP beats and the Russell 2000 rallies, with three of four large caps rising.